Hoi Ching Cheng

Analysis of Plasma Epstein-Barr Virus DNA in Nasopharyngeal Cancer After Chemoradiation to Identify High-Risk Patients for Adjuvant Chemotherapy: A Randomized Controlled Trial

Anthony T.�C. Chan, Edwin P. Hui, Roger K.C. Ngan et al. · Journal of Clinical Oncology · 2018 · 245 citations

Medicine, Oncology, Radiation Oncology +17

Whole-exome sequencing identifies <i>MST1R</i> as a genetic susceptibility gene in nasopharyngeal carcinoma

Wei Dai, Hong Zheng, Arthur Kwok Leung Cheung et al. · Proceedings of the National Academy of Sciences · 2016 · 92 citations · Full text

Medicine, Genetics, Oncology +17

A multicenter randomized controlled trial (RCT) of adjuvant chemotherapy (CT) in nasopharyngeal carcinoma (NPC) with residual plasma EBV DNA (EBV DNA) following primary radiotherapy (RT) or chemoradiation (CRT).

Anthony T.�C. Chan, Edwin P. Hui, Roger K.C. Ngan et al. · Journal of Clinical Oncology · 2017 · 21 citations

Medicine, Clinical Sciences, Radiation Oncology +15